Integrating AF4 with SAXS and SANS demonstrates how surfactant identity impacts lipid nanoparticles' morphology, implying better design strategies.
Precise mapping of structural heterogeneity at the sub-10 nm scale is pivotal for rational nanoparticle design, yet convention-al analytical workflows remain inadequate. Here we integrate dilution-controlled asymmetric flow field-flow fractionation (AF4) with small-angle X-ray scattering (SAXS) and small-angle neutron scattering (SANS) to interrogate ellipsoidal solid–liquid lipid nanoparticles (LNPs). The dilution-controlled AF4 mode amplifies scattering contrast, enabling robust, shape-resolved analysis across entire elution profiles. Coupling AF4 to SANS in D₂O further sharpens resolution for the smallest fractions by reducing particle diffusion through increased solvent viscosity. Comparative sizing shows that SAXS/SANS accurately capture primary particles down to ~5 nm, whereas multi-angle light scattering chiefly detects loosely associated aggregates. Morphology profiling reveals that surfactant identity governs particle shape, polydispersity, and overall architec-ture. Joint SAXS/SANS modelling uncovers a 2–3 nm polar shell enveloping the hydrophobic lipid core. Together, these insights refine our understanding of LNP size and morphology and establish dilution-controlled AF4-SAXS/SANS as a high-resolution platform for dissecting complex nanoparticle systems relevant to biomedical applications.
No takes yet. Share an insight, caveat, or question.
Bittrich et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: